Company Filing History:
2 out of 76 
2 out of 192 
1 out of 721 
Years Active: 2008-2018
Title: The Innovative Contributions of Andreas Geerts
Introduction
Andreas Geerts is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of medical research, particularly in the treatment of various diseases. With a total of 7 patents to his name, Geerts has demonstrated a commitment to advancing healthcare through innovative solutions.
Latest Patents
Geerts' latest patents include groundbreaking work on the use of cathepsin K inhibition for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure. This invention focuses on the application of cathepsin K and/or cathepsin S inhibitors in methods aimed at addressing these serious health conditions. Another significant patent involves the acylglycerol acyltransferase-like protein MGAT-X1, which is associated with a range of diseases including dermatological, urological, and neurological disorders. This invention not only provides a novel polynucleotide sequence but also outlines methods for identifying compounds that can modulate these diseases.
Career Highlights
Throughout his career, Geerts has worked with prominent companies such as Bayer Healthcare and Bayer Schering Pharma. His experience in these organizations has allowed him to collaborate on various innovative projects that have the potential to impact patient care positively.
Collaborations
Geerts has collaborated with notable colleagues, including Stefan Golz and Ulf Brüggemeier. These partnerships have contributed to the development of his patents and the advancement of medical research.
Conclusion
Andreas Geerts is a distinguished inventor whose work in the medical field has led to significant advancements in treatment options for various diseases. His innovative patents and collaborations reflect his dedication to improving healthcare outcomes.